Lexicon Pharmaceuticals | LXRX - Ordinary Share Capital

Stock Price
1.31
Daily Change
0 0%
Monthly
5.65%
Yearly
66.90%
Q1 Forecast
2.01

Lexicon Pharmaceuticals reported $245K in Ordinary Share Capital for its fiscal quarter ending in September of 2023.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Acadia Pharmaceuticals USD 168.71M 104K Sep/2025
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Akebia Therapeutics USD 2K 0 Mar/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Coherus Biosciences USD 12K 0 Mar/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Esperion Therapeutics USD 112K 11K Sep/2023
Halozyme Therapeutics USD 117.52M 98K Sep/2025
Illumina USD 152.8M 900K Dec/2025
Insmed USD 212.58M 210.76M Sep/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
J&J USD 2.41B 584K Sep/2025
MacroGenics USD 63.26M 62.63M Sep/2025
MannKind USD 307.03M 303.99M Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Moderna USD 391M 2M Sep/2025
Novartis USD 1.94B 23.4M Jun/2025
PTC Therapeutics USD 79.93M 554K Sep/2025
Puma Biotechnology USD 5K 0 Jun/2024
Sarepta Therapeutics USD 104.77M 7.06M Sep/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
Ultragenyx Pharmaceutical USD 96.44M 88K Sep/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
Vanda Pharmaceuticals USD 58K 0 Dec/2024